GRAL Investors Invited to Join Fraud Investigation

The Schall Law Firm announces investigation into GRAIL, Inc. over alleged securities law violations.

Apr. 3, 2026 at 10:05pm

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a stack of legal documents, a gavel, and a magnifying glass arranged on a clean, monochromatic background, conceptually representing a corporate fraud investigation.A legal investigation into alleged corporate fraud exposes the complex web of shareholder rights and securities law.Los Angeles Today

The Schall Law Firm, a national shareholder rights litigation firm, has announced an investigation on behalf of investors of GRAIL, Inc. (NASDAQ: GRAL) for potential violations of securities laws. The investigation focuses on whether the company issued false or misleading statements and failed to disclose information pertinent to investors.

Why it matters

GRAIL's announcement of disappointing results from the NHS-Galleri trial caused its stock price to drop sharply, leading to potential losses for investors. The Schall Law Firm's investigation could uncover evidence of fraud or other wrongdoing, which could have significant implications for GRAIL and its shareholders.

The details

The investigation centers around GRAIL's announcement on February 19, 2026, that the primary endpoint of statistically significant Stage III-IV reduction was not observed in the NHS-Galleri trial. This news led to a significant decline in the company's stock price.

  • GRAIL announced the NHS-Galleri trial results on February 19, 2026.

The players

The Schall Law Firm

A national shareholder rights litigation firm that is investigating potential securities law violations by GRAIL, Inc.

GRAIL, Inc.

A biotechnology company that develops cancer detection tests, whose stock price dropped after disappointing trial results.

Got photos? Submit your photos here. ›

What they’re saying

“We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.”

— Brian Schall, Attorney, The Schall Law Firm

What’s next

The Schall Law Firm is inviting GRAL investors to join the investigation and discuss their rights.

The takeaway

This investigation highlights the importance of transparency and accurate disclosure for publicly traded companies, as any evidence of fraud or misleading statements could have serious consequences for investors.